Creo Medical (1RC) Stock Statistics & Valuation Metrics
Total Valuation
Creo Medical has a market cap or net worth of EUR 58.59M. The enterprise value is EUR 57.72M.
- Market Cap
- EUR 58.59M
- Enterprise Value
- EUR 57.72M
Share Statistics
Creo Medical has 449,139,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 449,139,980
- Owned by Insiders
- 5.40%
- Owned by Institutions
- ―
Financial Efficiency
Creo Medical’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is -38.26%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- -38.26%
- Return on Capital Employed (ROCE)
- -0.40
- Revenue Per Employee
- 57.69K
- Profits Per Employee
- 50.96K
- Employee Count
- 104
- Asset Turnover
- 0.10
- Inventory Turnover
- 1.84
Valuation Ratios
The current PE Ratio of Creo Medical is -2.40. Creo Medical’s PEG ratio is 0.01.
- PE Ratio
- -2.40
- PS Ratio
- 6.98
- PB Ratio
- 0.94
- Price to FCF
- -1.12
- Price to Operating Cash Flow
- -1.04
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Creo Medical had revenue of 6.00M and earned 5.30M in profits. Earnings per share was 0.01.
- Revenue
- 6.00M
- Gross Profit
- 1.40M
- Operating Income
- -20.70M
- Pretax Income
- -17.50M
- Net Income
- 5.30M
- EBITDA
- -19.70M
- Earnings Per Share (EPS)
- 0.01
Cash Flow
In the last 12 months, operating cash flow was -18.90M and capital expenditures 0, giving a free cash flow of -18.90M billion.
- Operating Cash Flow
- -18.90M
- Free Cash Flow
- -18.90M
- Free Cash Flow per Share
- -0.10
Dividends & Yields
Creo Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -89.26%
- Earnings Yield
- -41.30%
Stock Price Statistics
- Beta
- 1.07
- 52-Week Price Change
- 1.63%
- 50-Day Moving Average
- 0.13
- 200-Day Moving Average
- 0.14
- Relative Strength Index (RSI)
- 48.18
- Average Volume (3m)
- ―
Important Dates
Creo Medical upcoming earnings date is Jun 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 30, 2026
- Next Earnings Date
- Jun 02, 2027
- Ex-Dividend Date
- ―
Financial Position
Creo Medical as a current ratio of 3.22, with Debt / Equity ratio of 8.20%
- Current Ratio
- 3.22
- Quick Ratio
- 2.88
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- 0.42
- Interest Coverage Ratio
- -69.00
Taxes
In the past 12 months, Creo Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Creo Medical EV to EBITDA ratio is -2.55, with an EV/FCF ratio of -1.04.
- EV to Sales
- 6.48
- EV to EBITDA
- -2.55
- EV to Free Cash Flow
- -1.04
- EV to Operating Cash Flow
- -1.04
Balance Sheet
Creo Medical has EUR 12.40M in cash and marketable securities with EUR 4.10M in debt, giving a net cash position of EUR 8.30M billion.
- Cash & Marketable Securities
- EUR 12.40M
- Total Debt
- EUR 4.10M
- Net Cash
- EUR 8.30M
- Net Cash Per Share
- EUR 0.02
- Tangible Book Value Per Share
- EUR 0.12
Margins
Gross margin is 28.57%, with operating margin of -267.14%, and net profit margin of -268.57%.
- Gross Margin
- 28.57%
- Operating Margin
- -267.14%
- Pretax Margin
- -571.43%
- Net Profit Margin
- -268.57%
- EBITDA Margin
- -254.29%
- EBIT Margin
- -267.14%
Scores
- Smart Score
- 3
- AI Score
- ―
